Dermaharmony Sulfur And Salicylic Acid Liquid
NDC Package 71819-006-99
Package Information
Dermaharmony Sulfur And Salicylic Acid (salicylic acid, sulfur) liquids is usesHelps prevent and control recurrence of itching, flaking and irritation associated with dandruff, sebhorreic dermatitis, and psoriasis. This formulation utilizes a liquid delivery system. Marketed by D3 Development, Inc., this product is identified by NDC 71819-006 and is authorized under FDA application M032.
Identification & Billing
- RxCUI: 2286294 - salicylic acid 2 % / sulfur 5 % Medicated Liquid Soap
- RxCUI: 2286294 - salicylic acid 20 MG/ML / sulfur 50 MG/ML Medicated Liquid Soap
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71819 - D3 Development, Inc.
- 71819-006 - Dermaharmony Sulfur And Salicylic Acid
- 71819-006-99 - 3785 mL in 1 BOTTLE, PLASTIC
- 71819-006 - Dermaharmony Sulfur And Salicylic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71819-006). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71819-006-99 identifies a specific commercial package of 3785 ml in 1 bottle, plastic of Dermaharmony Sulfur And Salicylic Acid, a human over the counter drug labeled by D3 Development, Inc.. This liquid is formulated for topical use and contains salicylic acid; sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by D3 Development, Inc. on March 27, 2020. The current certification is valid through December 31, 2026.
How is this D3 Development, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71819000699. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.